BioArctic AB - Class B

NEW
LTS:0RV2 (Sweden)   Class B
kr 170.80 (-1.9%) Dec 13
At Loss
P/B:
16.90
Market Cap:
kr 15.19B ($ 1.38B)
Enterprise V:
kr 14.64B ($ 1.33B)
Volume:
10.29K
Avg Vol (2M):
6.95K
Warning! GuruFocus detected 3 Severe warning signs with 0RV2. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
10.29K
Market Cap kr:
15.19B
Market Cap $:
1.38B
At Loss
Avg Vol (2M):
6.95K
Enterprise Value kr:
14.64B
Enterprise Value $:
1.33B
PB Ratio:
16.90
Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocks™

Business Description

BioArctic AB

ISIN : SE0010323311
https://www.bioarctic.se
Warfvinges vag 35, Stockholm, SWE, SE-112 51

Share Class Description:

LTS:0RV2: Class B
Compare
Compare
OSTO:CAMXOSTO:CALTXOSTO:GENOOSTO:VICOOSTO:EGTXOSTO:HNSAOSTO:IBT BOSTO:FLUOOSTO:BINVOSTO:XSPRAYOCSE:NOVO BVRTXREGNASX:CSLSGENXKRX:207940MRNAHKSE:02269XBRU:ARGXBNTX
Traded in other countries / regions
BIOA B.Sweden0RV2.UKBRCTF.USAB9A.Germany
IPO Date
2017-10-18
Description
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

Financial Strength

7/10
Name Current Vs Industry Vs History
Cash-To-Debt 10.72
Equity-to-Asset 0.84
Debt-to-Equity 0.06
Debt-to-EBITDA -0.25
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 56.17
Distress
Grey
Safe
Beneish M-Score -2.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

6/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 114.3
3-Year Book Growth Rate 4.8
Future 3-5Y Total Revenue Growth Rate Estimate 52.94

Momentum Rank

6/10
Name Current Vs Industry Vs History
5-Day RSI 18.76
9-Day RSI 35.73
14-Day RSI 44.24
3-1 Month Momentum % -15.08
6-1 Month Momentum % -34.81
12-1 Month Momentum % -43.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.35
Quick Ratio 8.35
Cash Ratio 5.1
Days Sales Outstanding 0.49
Days Payable 120.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1
Shareholder Yield % -0.15

Profitability Rank

5/10
Name Current Vs Industry Vs History
Gross Margin % 45.85
Operating Margin % -148.85
Net Margin % -139.32
FCF Margin % -97.61
ROE % -23.21
ROA % -20.11
ROIC % -54.2
3-Year ROIIC % -667.28
ROC (Joel Greenblatt) % -59.46
ROCE % -21.47
Years of Profitability over Past 10-Year 6

GF Value Rank

8/10
Name Current Vs Industry Vs History
Forward PE Ratio 50.89
Price-to-Owner-Earnings 67.09
PS Ratio 92.9
PB Ratio 16.9
Price-to-Tangible-Book 16.55
EV-to-EBIT -67.26
EV-to-Forward-EBIT 33.85
EV-to-EBITDA -67.26
EV-to-Forward-EBITDA 32.2
EV-to-Revenue 89.2
EV-to-Forward-Revenue 14.69
EV-to-FCF -95.95
Price-to-GF-Value 0.69
Price-to-Projected-FCF 22.5
Price-to-Net-Current-Asset-Value 18.65
Price-to-Net-Cash 35.36
Earnings Yield (Greenblatt) % -1.49
FCF Yield % -1.06

Financials (Next Earnings Date:2025-02-13)

LTS:0RV2's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BioArctic AB Executives

Details

GF Value: kr247.54

LTS:0RV2

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 167.141
EPS (TTM) (kr) -2.63
Beta -1.93
3-Year Sharpe Ratio 0.44
3-Year Sortino Ratio 1.53
Volatility % 44.01
14-Day RSI 44.24
14-Day ATR (kr) 7.846296
20-Day SMA (kr) 184.255
12-1 Month Momentum % -43.24
52-Week Range (kr) 137.9 - 287
Shares Outstanding (Mil) 88.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioArctic AB Filings

Filing Date Document Date Form
No Filing Data

BioArctic AB Stock Events

Financials Calendars
Event Date Price (kr)
No Event Data

BioArctic AB Frequently Asked Questions

What is BioArctic AB(LTS:0RV2)'s stock price today?
The current price of LTS:0RV2 is kr170.80. The 52 week high of LTS:0RV2 is kr287.00 and 52 week low is kr137.90.
When is next earnings date of BioArctic AB(LTS:0RV2)?
The next earnings date of BioArctic AB(LTS:0RV2) is 2025-02-13.
Does BioArctic AB(LTS:0RV2) pay dividends? If so, how much?
BioArctic AB(LTS:0RV2) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.